However, no significant association was noted between ATM mutation and age of onset (early-onset vs. late-onset) of BC, lymph node status, tumor stage, grade, estrogen receptor, progesterone receptor and Her-2 status (Table 4). This evidence concerns the gene ERBB2 and breast cancer.